Home/Filings/4/0001062993-24-020597
4//SEC Filing

Lucas Brent T. 4

Accession 0001062993-24-020597

CIK 0001840877other

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 4:10 PM ET

Size

10.3 KB

Accession

0001062993-24-020597

Insider Transaction Report

Form 4
Period: 2024-12-11
Lucas Brent T.
DirectorChief Executive Officer
Transactions
  • Purchase

    Warrant (right to buy)

    2024-12-11$0.06/sh+16,694$1,002110,987 total
    Exercise: $11.50Exp: 2028-09-29Class A Common Stock (16,694 underlying)
  • Purchase

    Warrant (right to buy)

    2024-12-11$0.06/sh+94,293$5,18694,293 total
    Exercise: $11.50Exp: 2028-09-29Class A Common Stock (94,293 underlying)
Holdings
  • Class A Common Stock

    203,578
  • Class A Common Stock

    (indirect: By Trust)
    12,720
  • Stock Option (right to buy)

    Exercise: $2.40Exp: 2033-10-15Class A Common Stock (879,749 underlying)
    879,749
Footnotes (3)
  • [F1]Includes 1,972 shares previously reported as held indirectly by spouse and 5,991 shares previously reported as held by an irrevocable trust.
  • [F2]Options to purchase 659,811 shares vest on 10/15/2023, and 219,938 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months.
  • [F3]Fully exercisable.

Issuer

Envoy Medical, Inc.

CIK 0001840877

Entity typeother

Related Parties

1
  • filerCIK 0001994382

Filing Metadata

Form type
4
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:10 PM ET
Size
10.3 KB